Navigation Links
Etirinotecan Pegol (NKTR-102) Passes Interim Efficacy Analysis for BEACON Pivotal Phase 3 Clinical Study in Patients with Metastatic Breast Cancer
Date:1/14/2014

advanced breast cancer, particularly for patients with HER2-negative breast cancer and triple-negative breast cancer." 

Positive Phase 2 data for NKTR-102 were recently published in Lancet Oncology in November 2013. (1)  Etirinotecan pegol achieved a confirmed objective response rate by RECIST of 29 percent. NKTR-102 demonstrated a high clinical benefit rate (CR+PR+SD greater than six months) of 37 percent (13/35) in the 14-day group and 49 percent (17/35) in the 21-day group. Six patients experienced 100 percent resolution of all target lesions, with two complete RECIST responses and four near-complete responses.
Patients treated exhibited low rates of alopecia, neuropathy and neutropenia, which are significant adverse events associated with existing breast cancer therapies. Side effects were generally manageable; the most common Grade 3 toxicity was diarrhea (17-23%) typically occurring after three months of therapy.

About the BEACON StudyBEACON is a Phase 3, open-label, randomized, multicenter study of NKTR-102 which enrolled 852 women with locally recurrent or metastatic breast cancer, who have previously been treated with ATC. The trial is being conducted at approximately 150 sites worldwide including North America, Western Europe, Russia and the Republic of Korea.  Nearly half of the patients enrolled in BEACON were located in North America.  Patients were randomized on a 1:1 basis to receive 145 mg/m2 of single-agent NKTR-102 once every three weeks or a single agent of physician's choice.  The physician's choice agents include: ixabepilone, vinorelbine, gemcitabine, eribulin, or a taxane.  Randomization was stratified by geographic region, prior use of eribulin and receptor status. 

The primary endpoint of the BEACON study is overall survival; secondary endpoints include progression-free survival, objective tumor response
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
2. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
3. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
4. Nektar Announces Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) in Patients with Bevacizumab (Avastin)-resistant High-Grade Glioma
5. CAS REGISTRY(SM) surpasses 75 million small molecules
6. WuXi Manufacturing Facility Passes FDA Inspection
7. Tecfideras Patient Share at Three Months Postlaunch Surpasses That for Aubagio and Gilenya At the Same Stage of Their Launches
8. Emotivs Brainwear Technology To Track Cognitive Health Surpasses $1M Kickstarter Stretch Goal
9. The Leukemia & Lymphoma Society Co-Pay Assistance Fund Surpasses $200 Million
10. French Man with SynCardia Total Artificial Heart Surpasses Two Years of Support
11. NABPs .PHARMACY Proposal Passes Initial ICANN Evaluation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)...  Tandem Diabetes Care ® , Inc. (NASDAQ: ... and manufacturer of the t:slim ® Insulin ... non-profit dedicated to improving diabetes therapy management by ... diabetes data accessibility. This partnership will enable users ... development, to download and access data from their ...
(Date:11/21/2014)... , Nov. 21, 2014  World Hemp Oil, ... low THC, announces they are now offering legal, organic ... Charlotte,s Web type strains grown in medical marijuana states. ... neurological disorders, such as Parkinson,s, MS, and spinal cord ... laws to pass, because imported CBD Oil Is legal ...
(Date:11/21/2014)... SOUTH PLAINFIELD, N.J. , Nov. 21, 2014  PTC ... announce that the 2014 Legend of Technology Award for Vision, ... Peltz , Ph.D., Chief Executive Officer. This award recognizes an ... industry in New Jersey for several ... Legend of Technology Award," stated Stuart Peltz , Ph.D., ...
Breaking Medicine Technology:Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 3New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 3PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 3
... prostate and ... colorectal cancer trials -, SOUTH SAN FRANCISCO, Calif., ... company focused,on oncology, today provided an update of its picoplatin development ... prostate cancer (HRPC), and its oral formulation in solid,tumors. Presenting at ...
... Also This Month: Lessons Learned from the Avandia ... older,adults with diabetes live longer when they are ... December issue of Diabetes Care, which,publishes on November ... is an editorial by U.S. Food and Drug,Administration ...
Cached Medicine Technology:Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference 2Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference 3Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference 4Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference 5Treating Depression Prolongs Life for Older People with Diabetes 2
(Date:11/23/2014)... November 23, 2014 The report, ... 2006 to 2020 - Asia-Pacific” provides quantitative analysis ... market segments: minimally invasive body contouring devices, non-invasive ... analysis includes market size data by revenue and ... following countries: China, Japan, South Korea, Australia and ...
(Date:11/23/2014)... SUNDAY, Nov. 23, 2014 (HealthDay News) -- The holidays ... autism because sensory overload can trigger major meltdowns, an ... under the best of circumstances, but when you have ... Varleisha Gibbs, an occupational therapy professor at University of ... release. "It,s best to let your hosts or ...
(Date:11/23/2014)... 2014 More than two dozen new ... federal litigation involving Byetta lawsuits ( http://www.byettalawsuit2013.com/ ), as ... LLP reports. , A Case List updated on ... of Type 2 diabetes medications referred to as incretin ... Court, Southern District of California, where a federal proceeding ...
(Date:11/23/2014)... Syngenta lawsuits are now being investigated by ... agribusinesses that have allegedly incurred significant financial damages due ... Agrisure Duracade, genetically modified (GMO) corn seed products ... China. According to a report from Bloomberg News, Syngenta’s ... imports. Because China is the third-largest American corn importer, ...
(Date:11/22/2014)... A new AlignLife Chiropractic & Natural Health ... Greenville area. Dr. Chelsea Sineath, owner and chiropractor at ... her own clinic after working in another AlignLife office ... , AlignLife believes that the body can heal itself ... chiropractic care and rehabilitation to allow the spine to ...
Breaking Medicine News(10 mins):Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 2Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 3Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 4Health News:Holidays Can Be Sensory Overload for Kids With Autism 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 3Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 4Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 3Health News:AlignLife of Downtown Greenville is Now Open and Accepting New Patients 2
... Identifying the public health and safety needs of ... art, report University of Pittsburgh researchers in the current ... Research, Education and Action . In their paper, researchers ... that engages community members as partners in research. ...
... only cause tumors, but promote growth, mouse study finds ... does cigarette smoke cause lung cancer, it worsens the ... , The team at the University of California, San ... early lung cancer lesions and found that those repeatedly ...
... ... team. The addition of a Rapid Prototyping line increases the flexibility and services available ... ... the addition of a high speed Rapid Prototyping line for its plant in Reno, Nevada. ...
... ... national debate on healthcare still churning, innovations in technology will have a ... been paid to electronic health records, there is a new breed of ... latest version of their online integrated health tracking tools, providing members ways ...
... DALLAS , Jan. 19 The American Stroke ... the Gospel Music Channel to educate people about stroke through an ... - April 6 , will engage competing choirs and voters from ... cause campaign. , Each choir who enters the competition is required ...
... , , WASHINGTON , Jan. ... will host its "2nd Annual World Congress Affordable Innovations ... conjunction  with the 7th Annual World Health Care Congress. ... can provide sustainable and scalable health solutions, often to ...
Cached Medicine News:Health News:Program uses art to engage at-risk kids 2Health News:EE Technologies Adds High Speed Rapid Prototyping Line in Reno 2Health News:Online Tools to Transform the Way People Manage Their Health 2Health News:Online Tools to Transform the Way People Manage Their Health 3Health News:Choirs To Raise Voices, Stroke Awareness Through Most Powerful Voices Competition 2Health News:Choirs To Raise Voices, Stroke Awareness Through Most Powerful Voices Competition 3Health News:Choirs To Raise Voices, Stroke Awareness Through Most Powerful Voices Competition 4Health News:World Congress Announces Affordable Innovations in Health Exhibit and Awards 2010 at 7th Annual World Health Care Congress, Calls for Submissions from Organizations Striving to Improve Global Health Care 2Health News:World Congress Announces Affordable Innovations in Health Exhibit and Awards 2010 at 7th Annual World Health Care Congress, Calls for Submissions from Organizations Striving to Improve Global Health Care 3
...
...
... The Premier Anterior Cervical Plate System ... screw translation along slots in the ... the distal end of the construct. ... has graft pre-compression features that enable ...
... for supportive stabilization of the anterior ... device utilizes bi-cortical fixation for stabilization. ... through dynamic screw holes and low ... interbody fusion. Anterior cervical corpectomy. Anterior ...
Medicine Products: